If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...

A groundbreaking gene therapy, VERVE-102, has shown promise in reducing "bad" cholesterol by up to 62% with a single ...

Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, ...

Experts say that the gene therapy could prove 'transformative' for patients by preventing future heart attacks or strokes.

Switching from daily pills for life to a single injection could revolutionise cholesterol treatment, especially for those ...

Scientists are testing a new gene-editing treatment that could dramatically lower bad cholesterol and reduce the risk of ...

One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up ...

A one-time gene-editing infusion kept cholesterol levels low for a year, offering a potential new approach to preventing ...

LLY's stock is still down year-to-date as AI-driven narratives have captured the bulk of investor attention and capital in ...

Medicine is shifting from treating disease to actively outsmarting it, with five major breakthroughs emerging in recent weeks ...

VERVE-102 is an investigational gene-editing treatment designed to permanently disable the PCSK9 gene in the liver, thereby ...

My generation—which is to say, the pillbox generation—came of age during the 1990s. The number of adults who were taking five ...